China SXT Pharmaceuticals Inc (NASDAQ:SXTC) was the target of a significant increase in short interest in March. As of March 13th, there was short interest totalling 523,200 shares, an increase of 628.7% from the February 27th total of 71,800 shares. Based on an average daily trading volume, of 2,324,100 shares, the days-to-cover ratio is presently 0.2 days. Currently, 3.9% of the company’s stock are sold short.
An institutional investor recently raised its position in China SXT Pharmaceuticals stock. Renaissance Technologies LLC grew its position in shares of China SXT Pharmaceuticals Inc (NASDAQ:SXTC) by 806.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 178,601 shares of the company’s stock after purchasing an additional 158,900 shares during the quarter. Renaissance Technologies LLC owned 0.64% of China SXT Pharmaceuticals worth $146,000 as of its most recent filing with the SEC. 7.94% of the stock is owned by institutional investors.
NASDAQ:SXTC opened at $0.60 on Friday. China SXT Pharmaceuticals has a 52 week low of $0.50 and a 52 week high of $9.24. The business’s 50 day moving average is $0.84 and its two-hundred day moving average is $1.04.
China SXT Pharmaceuticals Company Profile
China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives.
Featured Story: Cost of equity and a company’s balance sheet
Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.